Home Cart 0 Sign in  
X

[ CAS No. 29335-36-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 29335-36-2
Chemical Structure| 29335-36-2
Chemical Structure| 29335-36-2
Structure of 29335-36-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 29335-36-2 ]

Related Doc. of [ 29335-36-2 ]

Alternatived Products of [ 29335-36-2 ]

Product Details of [ 29335-36-2 ]

CAS No. :29335-36-2 MDL No. :MFCD03426272
Formula : C3H8N2O Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 88.11 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 29335-36-2 ]

Physicochemical Properties

Num. heavy atoms : 6
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 3.0
Molar Refractivity : 23.66
TPSA : 56.11 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.11 cm/s

Lipophilicity

Log Po/w (iLOGP) : -2.29
Log Po/w (XLOGP3) : -0.39
Log Po/w (WLOGP) : 0.35
Log Po/w (MLOGP) : -0.04
Log Po/w (SILICOS-IT) : -0.67
Consensus Log Po/w : -0.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.01
Solubility : 86.4 mg/ml ; 0.98 mol/l
Class : Very soluble
Log S (Ali) : -0.32
Solubility : 41.7 mg/ml ; 0.473 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.14
Solubility : 63.8 mg/ml ; 0.724 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.88

Safety of [ 29335-36-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 29335-36-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 29335-36-2 ]
  • Downstream synthetic route of [ 29335-36-2 ]

[ 29335-36-2 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 107-12-0 ]
  • [ 29335-36-2 ]
YieldReaction ConditionsOperation in experiment
81% With hydroxylamine hydrochloride; potassium carbonate In ethanol; water at 20℃; for 20 h; Reflux Hydroxylamine hydrochloride (18.9 g, 272.7 mmol) and anhydrous potassium carbonate (37.6 g, 272.7 mmol) were suspended in EtOH /H2O (200 mL / 50 mL) and the mixture was stirred at room temperature for 1 hour before the addition of propionitrile (10.0 g, 181.8 mmol). The resulting mixture was heated to reflux and stirred for 20 hours and the reaction was monitored by thin-layer chromatography (DCM / MeOH, v / v, 50/1). anti-At the end of this time, the inorganic salt was removed by filtration and the filtrate was concentrated under reduced pressure to give the title compound as a pale yellow solid (13.5 g,81percent).
Reference: [1] Patent: CN104513235, 2017, B, . Location in patent: Paragraph 1308; 1309
[2] Chemische Berichte, 1884, vol. 17, p. 2753
[3] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1957, vol. 245, p. 419,420
[4] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1966, vol. 262, p. 592 - 595
[5] Monatshefte fuer Chemie, 1982, vol. 113, p. 781 - 792
[6] Patent: US5043342, 1991, A,
[7] Journal of Medicinal Chemistry, 2008, vol. 51, # 17, p. 5172 - 5175
[8] Patent: US2010/144681, 2010, A1, . Location in patent: Page/Page column 114
[9] Patent: WO2010/102218, 2010, A1, . Location in patent: Page/Page column 97
[10] Patent: WO2006/40192, 2006, A1, . Location in patent: Page/Page column 38-39
[11] Patent: WO2011/85406, 2011, A1, . Location in patent: Page/Page column 103
[12] Organic Process Research and Development, 2011, vol. 15, # 6, p. 1344 - 1347
[13] Patent: WO2012/33956, 2012, A1, . Location in patent: Page/Page column 124
  • 2
  • [ 1738-36-9 ]
  • [ 29335-36-2 ]
  • [ 95298-88-7 ]
Reference: [1] Patent: US4771051, 1988, A,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 29335-36-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 3599-89-1

[ 3599-89-1 ]

Propionimidamide hydrochloride

Similarity: 0.62

Chemical Structure| 849833-56-3

[ 849833-56-3 ]

(Z)-N'-Hydroxyisobutyrimidamide

Similarity: 0.59

Chemical Structure| 22007-68-7

[ 22007-68-7 ]

Isobutyrimidamide hydrochloride

Similarity: 0.54

Chemical Structure| 22059-22-9

[ 22059-22-9 ]

N'-Hydroxyacetimidamide

Similarity: 0.52

Chemical Structure| 18202-73-8

[ 18202-73-8 ]

Pivalimidamide hydrochloride

Similarity: 0.52

Amidines

Chemical Structure| 51285-13-3

[ 51285-13-3 ]

N-Hydroxycyclopropanecarboximidamide

Similarity: 0.74

Chemical Structure| 3599-89-1

[ 3599-89-1 ]

Propionimidamide hydrochloride

Similarity: 0.62

Chemical Structure| 849833-56-3

[ 849833-56-3 ]

(Z)-N'-Hydroxyisobutyrimidamide

Similarity: 0.59

Chemical Structure| 22007-68-7

[ 22007-68-7 ]

Isobutyrimidamide hydrochloride

Similarity: 0.54

Chemical Structure| 22059-22-9

[ 22059-22-9 ]

N'-Hydroxyacetimidamide

Similarity: 0.52

Amines

Chemical Structure| 51285-13-3

[ 51285-13-3 ]

N-Hydroxycyclopropanecarboximidamide

Similarity: 0.74

Chemical Structure| 3599-89-1

[ 3599-89-1 ]

Propionimidamide hydrochloride

Similarity: 0.62

Chemical Structure| 849833-56-3

[ 849833-56-3 ]

(Z)-N'-Hydroxyisobutyrimidamide

Similarity: 0.59

Chemical Structure| 22007-68-7

[ 22007-68-7 ]

Isobutyrimidamide hydrochloride

Similarity: 0.54

Chemical Structure| 22059-22-9

[ 22059-22-9 ]

N'-Hydroxyacetimidamide

Similarity: 0.52

Oximes

Chemical Structure| 51285-13-3

[ 51285-13-3 ]

N-Hydroxycyclopropanecarboximidamide

Similarity: 0.74

Chemical Structure| 849833-56-3

[ 849833-56-3 ]

(Z)-N'-Hydroxyisobutyrimidamide

Similarity: 0.59

Chemical Structure| 22059-22-9

[ 22059-22-9 ]

N'-Hydroxyacetimidamide

Similarity: 0.52